In this episode of The Digital Executive, host Brian Thomas welcomes Shane Barker, CEO and founder of TraceFuse—the first Amazon terms of service (TOS) compliant negative review removal platform. With over 25 years of digital marketing experience and a history of working with Fortune 500 brands, Shane shares how he built a SaaS solution that helps Amazon sellers safeguard their brand reputation and revenue.Shane explains the two-year journey it took to develop Trace Fuse, why existing tools fell short, and how his team combined AI with human oversight to successfully remove more than 14,000 non-compliant reviews for over 600 brands. He dives into common violations like competitor mentions, pricing references, and inappropriate language, while also reflecting on the limitations when unfair but compliant reviews can’t be challenged.The conversation highlights how Trace Fuse balances automation with the human touch to stay fully compliant with Amazon’s rules, and why AI has become essential to scale review monitoring across hundreds of thousands of listings.If you liked what you heard today, please leave us a review - Apple or Spotify. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
Before the Crisis: How You and Your Relatives Can Prepare for Financial Caregiving
06 Dec 2025
Motley Fool Money
OpenAI's Code Red, Sacks vs New York Times, New Poverty Line?
06 Dec 2025
All-In with Chamath, Jason, Sacks & Friedberg
OpenAI's Code Red, Sacks vs New York Times, New Poverty Line?
06 Dec 2025
All-In with Chamath, Jason, Sacks & Friedberg
Anthropic Finds AI Answers with Interviewer
05 Dec 2025
The Daily AI Show
#2423 - John Cena
05 Dec 2025
The Joe Rogan Experience
Warehouse to wellness: Bob Mauch on modern pharmaceutical distribution
05 Dec 2025
McKinsey on Healthcare